Its cost savings would include a cut of $1.1 billion from research and development from 2026, with most of the actions in 2027. "I hope you can see...why we're daunted by the commercial challenge of launching all those products really just in the next three years, and that causes us to want to actually start to pace ourselves," Moderna President Stephen Hoge said.
from Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/ZWQbE7G
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment